Although the role of RXFP1 in cancer has not been fully understood, it has emerged as a therapeutic target to reverse the procancer effects of increased relaxin (recently reviewed by Thanasupawat et al., 2019) (Thanasupawat et al., 2019). The gene discussed is RXFP1; the disease is cancer.